Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 8, 1999, Pages 1041-1045

  Barbezat, G O ^a   Schlup, M ^a   Lubcke, R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGUS DILATATION; ESOPHAGUS STRICTURE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH ACID SECRETION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; DILATATION; ENZYME INHIBITORS; ESOPHAGEAL STENOSIS; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; RETROSPECTIVE STUDIES;

EID: 0032816458     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00582.x     Document Type: Article

References (11)

1. 1 De Caestecker JS, Blackwell JN, Pryde A, et al. Daytime gastrooesophageal reflux is important in oesophagitis. Gut 1987; 28: 519-26.
2. 2 Robertson M, Aldersley M, Shepherd H, et al. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 1484-8.
3. 3 Holloway RH, Dent J, Narielvala F, et al. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut 1996; 38: 649-56.
4. 4 Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992; 51(Suppl. 1): 59-67.
5. 5 Ruth M, Enbom H, Lundell H, et al. The effect of omeprazole or ranitidine treatment on 24-hr oesophageal acidity in patients with reflux oesophagitis. Scand J Gastroenterol 1988; 23: 1141-6.
6. 6 DeVault KR, Castell DO, Guidelines for the diagnosis and treatment of gastrooesophageal reflux disease. Arch Intern Med 1995; 155: 2165-73.
7. 2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994; 106: 907-15.
8. 8 Swarbrick ET, Gough AL, Koster CS, et al. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. Eur J Gastroenterol Hepatol 1996; 8: 431-8.
9. 9 Dent J. Australian clinical trials of omeprazole in the management of reflux oesophagitis. Digestion 1990; 47(Suppl. 1): 69-71.
10. 10 Kubik CM, Polhamus CD, Clement DJ. Endoscopic steroid injection therapy for refractory esophageal strictures. Am J Gastroenterol 1994; 89: 1621 (Abstract).
11. 11 Coley CM, Barry MJ, Spechler SJ, et al. Initial medical v surgical therapy for complicated or chronic gastroesophageal reflux disease (GERD): a cost-effective analysis. Gastroenterology 1993; 104: A5(Abstract).